Jindal Drugs Profile
Key Indicators
- Authorised Capital ₹ 27.26 Cr
- Paid Up Capital ₹ 11.96 Cr
- Company Age 42 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 666.00 Cr
- Satisfied Charges ₹ 797.98 Cr
- Revenue Growth -1.61%
- Profit Growth -19.04%
- Ebitda -38.01%
- Net Worth 8.08%
- Total Assets 18.14%
About Jindal Drugs
Jindal Drugs Private Limited (JDPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 04 November 1982 and has a history of 42 years and two months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Jindal Dye Intermediate Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 27.26 Cr and a paid-up capital of Rs 11.96 Cr.
The company currently has active open charges totaling ₹666.00 Cr. The company has closed loans amounting to ₹797.98 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ajay Jindal, Shrikrishan Jindal, Krishnabai Jindal, and Three other members serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24114MH1982PTC028621
-
Company No.
028621
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Nov 1982
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Jindal Drugs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Jindal
|
Managing Director | 01-Oct-2011 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Ishaan Jindal
|
Director | 08-Jul-2019 | Current |
|
Shrikrishan Jindal
|
Whole-Time Director | 01-Oct-2011 | Current |
|
Krishnabai Jindal
|
Whole-Time Director | 23-Mar-2015 | Current |
|
Mamta Jindal
|
Whole-Time Director | 23-Mar-2015 | Current |
|
Aashna Jindal
|
Whole-Time Director | 24-Oct-2017 | Current |
Financial Performance of Jindal Drugs.
Jindal Drugs Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 1.61% decrease. The company also saw a substantial fall in profitability, with a 19.04% decrease in profit. The company's net worth moved up by a moderate rise of 8.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jindal Drugs?
In 2020, Jindal Drugs had a promoter holding of 98.36% and a public holding of 1.65%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Jindal Multitrade Private LimitedAjay Jindal and Shrikrishan Jindal are mutual person
-
Jogmaz Holding And Investments Private Limited
Ajay Jindal and Mamta Jindal are mutual person
-
Eskay Management Services Pvt Ltd
Ajay Jindal, Shrikrishan Jindal and 2 more are mutual person
-
Jogmaz Organic Industries Private Limited
Ajay Jindal and Mamta Jindal are mutual person
Charges (Loans)
₹666.00 Cr
₹797.98 Cr
Charges Breakdown by Lending Institutions
- Sbicap Trustee Company Limited : 600.00 Cr
- Others : 50.00 Cr
- Oversea- Chinese Banking Corp Ltd : 16.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Oct 2022 | Others | ₹50.00 Cr | Open |
| 25 Mar 2014 | Sbicap Trustee Company Limited | ₹600.00 Cr | Open |
| 19 Jul 1998 | Oversea- Chinese Banking Corp Ltd | ₹8.00 Cr | Open |
| 14 Jul 1998 | Oversea- Chinese Banking Corp Ltd | ₹8.00 Cr | Open |
| 17 Jun 2020 | Others | ₹9.09 Cr | Satisfied |
How Many Employees Work at Jindal Drugs?
Jindal Drugs has a workforce of 47 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jindal Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jindal Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
